Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropeptides B and W receptor 2 is a G protein-coupled receptor that binds and responds to neuropeptides B and W, with expression primarily in the frontal cortex and other CNS regions. It plays key regulatory roles in neuroendocrine signaling, modulation of feeding and energy balance, cardiovascular function, pain, and emotion. Structurally, it is homologous to opioid and somatostatin receptors but has specificity for the aforementioned neuropeptides. It is regarded as a valid therapeutic target, especially in research on appetite regulation, emotional modulation, and metabolic disease. No selective drugs for this receptor are approved, and the translational therapeutic implications are still largely investigational.
Ligand binding (neuropeptide B or W) activates the receptor, which is coupled to Gi proteins, affecting intracellular cAMP and signaling cascades Opioid and somatostatin-related signaling mechanisms due to structural similarity, though true selectivity is for neuropeptides B and W
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptides B and W receptor 2 (NPBWR2 (also known as NPBW2; previous symbol: GPR8)).